Antonio Girolami

Q: What Schools Are Affiliated With Antonio Girolami

Antonio Girolami is affiliated with the following schools: University of Vermont, Imperial College London, University of Oxford, Yamagata University, University of Padua, University of Basilicata

Antonio Girolami's AcademicInfluence.com Rankings

Antonio Girolami

Computer Science

#4461

World Rank

#4704

Historical Rank

Algorithms

#145

World Rank

#147

Historical Rank

Computational Linguistics

#431

World Rank

#438

Historical Rank

Machine Learning

#878

World Rank

#890

Historical Rank

computer-science Degrees

Antonio Girolami

Mathematics

#5619

World Rank

#7895

Historical Rank

Measure Theory

#841

World Rank

#1108

Historical Rank

mathematics Degrees

Download Badge

Computer Science
Mathematics

Antonio Girolami's Degrees

Bachelors Mathematics University of Oxford

Similar Degrees You Can Earn

Best Online Bachelor's in Math 2025

Why Is Antonio Girolami Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Antonio Girolami's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. (2002) (1681)
Heparin-induced thrombocytopenia. (2000) (1057)
Accuracy of clinical assessment of deep-vein thrombosis (1995) (738)
An association between atherosclerosis and venous thrombosis. (2003) (625)
Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. (1997) (528)
Residual Venous Thrombosis as a Predictive Factor of Recurrent Venous Thromboembolism (2002) (527)
Below-Knee Elastic Compression Stockings To Prevent the Post-Thrombotic Syndrome (2004) (399)
The risk of recurrent venous thromboembolism in patients with an Arg506-->Gln mutation in the gene for factor V (factor V Leiden). (1997) (391)
The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. (1997) (354)
Incidence of Venous Thromboembolism in Families with Inherited Thrombophilia (1999) (334)
Extensive screening for occult malignant disease in idiopathic venous thromboembolism: a prospective randomized clinical trial (2004) (326)
A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis (1993) (304)
Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. (1999) (273)
The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study. (2003) (267)
D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study (1998) (235)
The Risk of Abortion and Stillbirth in Antithrombin-, Protein C-, and Protein S-deficient Women (1996) (233)
Frequency of Pregnancy-Related Venous Thromboembolism in Anticoagulant Factor-Deficient Women: Implications for Prophylaxis (1996) (217)
The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study. (1999) (183)
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. (2002) (182)
von Willebrand factor interaction with the glycoprotein IIb/IIa complex. Its role in platelet function as demonstrated in patients with congenital afibrinogenemia. (1986) (176)
Vein abnormalities and the post‐thrombotic syndrome (2005) (170)
Reduced von Willebrand factor survival in type Vicenza von Willebrand disease. (2002) (170)
The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study (2004) (156)
Consumer liking and willingness to pay for high welfare animal-based products (2010) (154)
Interaction of asialo von Willebrand factor with glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and mediates platelet aggregation. (1985) (153)
Measurement of meat color using a computer vision system. (2013) (152)
Recurrence of venous thromboembolism in patients with familial thrombophilia. (1997) (152)
Cancer and venous thromboembolism: an overview. (1999) (149)
Heparin-induced thrombocytopenia: a review. (2006) (142)
A simple clinical model for the diagnosis of deep‐vein thrombosis combined with impedance plethysmography: potential for an improvement in the diagnostic process (1998) (135)
Hyperhomocysteinemia and Deep-Vein Thrombosis A Case-Control Study (1996) (131)
The Diagnostic Value of Compression Ultrasonography in Patients with Suspected Recurrent Deep Vein Thrombosis (2002) (123)
Effect of information about animal welfare on consumer willingness to pay for yogurt. (2008) (122)
Prolonged thromboprophylaxis with oral anticoagulants after total hip arthroplasty: a prospective controlled randomized study. (2002) (116)
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. (1995) (115)
Interaction of purified type IIB von Willebrand factor with the platelet membrane glycoprotein Ib induces fibrinogen binding to the glycoprotein IIb/IIIa complex and initiates aggregation. (1985) (105)
Acute coronary disease in essential thrombocythemia and polycythemia vera (1998) (104)
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. (1999) (103)
Factor VII Padua: a congenital coagulation disorder due to an abnormal factor VII with a peculiar activation pattern. (1978) (103)
Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. (2002) (102)
4G/5G Polymorphism of PAI-1 Gene Promoter and Fibrinolytic Capacity in Patients with Deep Vein Thrombosis (1998) (100)
The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study. (2002) (100)
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state (1992) (100)
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. (1994) (98)
Severe Arterial Cerebral Thrombosis in a Patient with Protein S Deficiency (Moderately Reduced Total and Markedly Reduced Free Protein S): A Family Study (1989) (97)
Deep Venous Thrombosis and Lupus Anticoagulant (1996) (94)
Safety of dental extraction among consecutive patients on oral anticoagulant treatment managed using a specific dental management protocol (2003) (91)
Effect of artificial rearing on lamb welfare and meat quality. (2002) (90)
Fatty acid profile, cholesterol content and tenderness of meat from Podolian young bulls. (2004) (89)
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review (2006) (89)
Fatty acid profile, cholesterol content and tenderness of ostrich meat as influenced by age at slaughter and muscle type. (2003) (87)
“Pseudo Homozygous” Activated Protein C Resistance due to Double Heterozygous Factor V Defects (Factor V Leiden Mutation and Type I Quantitative Factor V Defect) Associated with Thrombosis: Report of Two Cases Belonging to Two Unrelated Kindreds (1996) (87)
Failure of B cells of chronic lymphocytic leukemia in presenting soluble and alloantigens. (1995) (86)
The Occasional Venous Thromboses Seen in Patients with Severe (Homozygous) FXII Deficiency are Probably Due to Associated Risk Factors: A Study of Prevalence in 21 Patients and Review of the Literature (2004) (85)
Comparison of the Accuracy of Impedance Plethysmography and Compression Ultrasonography in Outpatients with Clinically Suspected Deep Vein Thrombosis (1995) (84)
Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. (1999) (84)
Further Studies on the Hypercoagulable State of Patients with Cushing’s Syndrome (1985) (84)
Increased Factor VIII Associated Activities in Cushing's Syndrome: A Probable Hypercoagulable State (1982) (84)
Antiphospholipid Antibodies, Recurrent Thromboembolism, and Intensity of Warfarin Anticoagulation (1996) (83)
Age as the major predictive factor of long‐term response to splenectomy in immune thrombocytopenic purpura (2001) (83)
Effect of age at slaughter on carcass traits, fatty acid composition and lipid oxidation of Apulian lambs (1999) (75)
Prothrombin fragment 1+2 and thrombin–antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation (1996) (74)
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases (2006) (74)
Hepatocellular carcinoma in hemophilia (1991) (73)
Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. (1998) (72)
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis (1986) (68)
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant (1998) (68)
The PAI-I gene 4G/5G Polymorphism and Deep Vein Thrombosis in Patients with Inherited Thrombophilia (2003) (68)
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutationRisk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis (2000) (68)
Myocardial Infarction and Other Arterial Occlusions in Hemophilia A Patients (2006) (66)
High incidence of anti‐FVIII antibodies against non‐coagulant epitopes in haemophilia A patients: a possible role for the half‐life of transfused FVIII (1996) (66)
Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. (2000) (66)
The Hereditary Transmission of Congenital ‘True’Hypoprothrombinaemia (1971) (64)
Variant Bernard-Soulier syndrome type bolzano. A congenital bleeding disorder due to a structural and functional abnormality of the platelet glycoprotein Ib-IX complex. (1990) (64)
The Risk of Fetal Loss in Family Members of Probands with Factor V Leiden Mutation (1999) (64)
Risk factors for thrombosis in patients with immune mediated heparin‐induced thrombocytopenia (2002) (63)
Congenital deficiencies and abnormalities of prothrombin. (1998) (63)
Reduced fibrinolytic potential one year after kidney transplantation. Relationship to long-term steroid treatment. (1995) (60)
Antiplatelet therapy and other interventions after revascularisation procedures in patients with peripheral arterial disease: a meta-analysis. (2000) (59)
Comparison of Real-Time B-Mode Ultrasonography and Doppler Ultrasound with Contrast Venography in the Diagnosis of Venous Thrombosis in Symptomatic Outpatients (1993) (58)
Thrombosis and hemorrhage in thrombocytosis: evaluation of a large cohort of patients (357 cases). (1991) (58)
Specific antiplatelet autoantibodies in patients with antiphospholipid antibodies and thrombocytopenia (1994) (56)
An Arg760Cys mutation in the consensus sequence of the von Willebrand factor propeptide cleavage site is responsible for a new von Willebrand disease variant. (2003) (56)
Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. (1991) (56)
Role of the 4G/5G Polymorphism of PAI-1 Gene Promoter on PAI-1 Levels in Obese Patients (2001) (56)
Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT 20210G/A) affecting the prothrombinase complex in a thrombophilic family. (2000) (56)
Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women. (2001) (55)
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. (1996) (54)
Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis. (1998) (54)
Rarer quantitative and qualitative abnormalities of coagulation. (1985) (53)
Psychological aspects and coping styles of parents with Haemophilic child undergoing a programme of counselling and psychological support (2007) (53)
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature (2009) (52)
Does Hemophilia Protect Against Atherosclerosis? A Case-Control Study (2006) (52)
Sensory evaluation of young goat meat. (1998) (52)
Antithrombotic Drugs in the Primary Medical Management of Intermittent Claudication: A Meta-analysis (1999) (51)
Hemophilia A, von Willebrand Disease, and Atherosclerosis of Abdominal Aorta and Leg Arteries: Factor VIII and von Willebrand Factor Defects Appear to Protect Abdominal Aorta and Leg Arteries From Atherosclerosis (2001) (51)
Congenital prekallikrein deficiency (2010) (50)
Main clinical manifestations of a bleeding diathesis: an often disregarded aspect of medical and surgical history taking (2005) (50)
Do Hemophilia A and von Willebrand Disease Protect Against Carotid Atherosclerosis? A Comparative Study Between . Coagulopathics and Normal Subjects by Means of Carotid Echo-Color Doppler Scan (1999) (50)
Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature (2006) (50)
Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors. (1987) (49)
Prothrombin padua: a "new" congenital dysprothrombinemia. (1974) (48)
Post-DDAVP Thrombocytopenia in Type 2B von Willebrand Disease Is not Associated with Platelet Consumption: Failure to Demonstrate Glycocalicin Increase or Platelet Activation (1999) (48)
C-Reactive Protein in Hypertensive Disorders in Pregnancy (2006) (48)
Myocardial Infarction, Other Arterial Thrombosis and Invasive Coronary Procedures, in Hemaophilia B: A Critical Evaluation of Reported Cases (2005) (48)
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7) (1992) (47)
Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature (2007) (47)
The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications. (1998) (47)
Effect of forage to concentrate ratio on growth performance, and on carcass and meat quality of Podolian young bulls. (2006) (46)
Consumer preference for chicken breast may be more affected by information on organic production than by product sensory properties. (2013) (46)
Multicenter Evaluation of a Chromogenic Substrate Method for Photometric Determination of Prothrombin Time (1987) (45)
Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. (2002) (45)
Effect of information about animal welfare, expressed in terms of rearing conditions, on lamb acceptability. (2007) (45)
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. (1997) (45)
Platelet-associated autoantibodies as detected by a solid-phase modified antigen capture ELISA test (MACE) are a useful prognostic factor in idiopathic thrombocytopenic purpura. (2004) (44)
Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern. (1979) (44)
Mild bleeding diathesis in a boy with combined severe haemophilia B (C10400→T) and heterozygous factor V Leiden (2001) (44)
Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa. (1990) (43)
The release of β‐ thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery (1981) (42)
Symptomatic deep-vein thrombosis and the post-thrombotic syndrome. (1995) (42)
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co‐factor activity? (2001) (41)
Psychological aspects and coping in haemophilic patients: a case–control study (2003) (41)
Behaviour and meat production of organically farmed unweaned lambs (2002) (41)
A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. (1989) (39)
Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients. (2000) (39)
Leukemia and Myelodysplasia Effect of Multiple Cytotoxic Therapy in Essential Thrombocythemia (2000) (39)
Congenital bleeding disorders of the vitamin K-dependent clotting factors. (2008) (38)
Prothrombin Molise: a "new" congenital dysprothrombinemia, double heterozygosis with an abnormal prothrombin and "true" prothrombin deficiency. (1978) (38)
Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency. (1977) (38)
Congenital FVII deficiency and thrombotic events after replacement therapy (2011) (38)
Anti-β2-Glycoprotein I Antibodies in Patients with Acute Venous Thromboembolism (1999) (38)
Isolation and characterization of an antifactor V antibody causing activated protein C resistance from a patient with severe thrombotic manifestations. (2002) (37)
Nomograms for the Administration of Unfractionated Heparin in the Initial Treatment of Acute Thromboembolism – an Overview (2000) (37)
Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy (2003) (37)
The Utility of Non-invasive Tests for Detection of Previous Proximal-vein Thrombosis (1995) (37)
1-Desamino-8-D-Arginine Vasopressin (DDAVP) Infusion in Type IIB von Willebrand’s Disease: Shortening of Bleeding Time and Induction of a Variable Pseudothrombocytopenia (1990) (37)
Molecular Bases of Pseudo-homozygous APC Resistance: The Compound Heterozygosity for FV R506Q and a FV Null Mutation Results in the Exclusive Presence of FV Leiden Molecules in Plasma (1998) (36)
Contraceptive pills induce an improvement in congenital hypoplasminogenemia in two unrelated patients with ligneous conjunctivitis (2003) (36)
Response to splenectomy in idiopathic thrombocytopenic purpura: prognostic value of the clinical and laboratory evaluation. (1989) (36)
The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: a study of six patients. (1991) (36)
Occurrence of arterial thrombosis in a cohort of patients with hereditary deficiency of clotting inhibitors. (1992) (36)
State-of-the-Art-Review : Essential Thrombocythemia in Young Adults: Major Thrombotic Complications and Complications During Pregnancy—A Follow-up Study in 68 Patients (2000) (35)
Venous and arterial thrombophilia. (1997) (35)
Efficacy of AT in pre-eclampsia: a case-control prospective trial (2003) (35)
Severe prekallikrein (Fletcher factor) deficiency due to a compound heterozygosis (383Trp stop codon and Cys529Tyr) (2003) (35)
Hypercoagulable State Induced in Humans by the Intravenous Administration of Purified Ellagic Acid (1967) (34)
Are Antiphospholipid Antibodies an Independent Risk Factor for Atherosclerosis? (2002) (34)
Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation. (1997) (34)
Heterozygous type I plasminogen deficiency is associated with an increased risk for thrombosis: a statistical analysis in 20 kindreds (1994) (34)
Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism. (1999) (33)
The effect of ellagic acid on coagulation in vivo. (1966) (33)
Pregnancy and oral contraceptives in factor V deficiency: a study of 22 patients (five homozygotes and 17 heterozygotes) and review of the literature (2005) (33)
Myocardial Infarction and Arterial Thrombosis in Severe (Homozygous) FXII Deficiency: No Apparent Causative Relation (2005) (33)
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. (1997) (33)
Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies. (1996) (33)
Which Is the Outcome of the Post-thrombotic Syndrome? (1999) (33)
Contact phase of blood coagulation in diabetes mellitus (1982) (32)
Effect of prolonged coumadin treatment on the production of pulmonary metastases in the rat (1966) (32)
A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg‐1 results in a strongly reduced affinity for binding of Ca++ (1993) (31)
Impaired release of tissue plasminogen activator (t‐PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content (1992) (31)
Clotting changes in Cushing's syndrome: elevated factor VIII activity. (1983) (31)
Clotting inhibitors and fibronectin as potential markers in preeclampsia (1994) (31)
Methodological approach to evaluate the effects of age at slaughter and storage temperature and time on sensory profile of lamb meat. (1999) (31)
Klippel-Trenaunay Syndrome, Visceral Angiomatosis and Thrombocytopenia (1968) (31)
The pathogenesis of venous thromboembolism. (1995) (31)
Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. (1986) (30)
Clinical and laboratory factors that affect the post-transfusion platelet increment. (2000) (30)
Normal and low molecular weight heparins: interaction with human platelets (1983) (30)
Type IIB von Willebrand factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets. (1995) (30)
The dysfunction of coagulation factor VIIPadua results from substitution of arginine-304 by glutamine. (1993) (30)
Congenital factor X deficiencies with a defect only or predominantly in the extrinsic or in the intrinsic system: A critical evaluation (2008) (29)
Prothrombin and the prothrombin 20210 G to A polymorphism: their relationship with hypercoagulability and thrombosis. (1999) (29)
Factor V Leiden and thrombophilia. (1995) (29)
Factor X Padua: a 'new' congenital factor X abnormality with a defect only in the extrinsic system. (1985) (29)
Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation (2010) (29)
Image analysis with the computer vision system and the consumer test in evaluating the appearance of Lucanian dry sausage. (2014) (29)
Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders. (2005) (29)
Studies on factor XIII antigen in congenital factor XIII deficiency. A tentative classification of the disease in two groups. (1978) (29)
Combined congenital deficiency of factor V and factor VIII. Report of a further case with some considerations on the hetereditary transmission of this disorder. (1976) (29)
The evaluation of factor VIII antigen by means of a simple slide test. (1985) (29)
Evaluation of activated protein C resistance in stored plasma (1994) (29)
Use of an Algorithm for Administering Subcutaneous Heparin in the Treatment of Deep Venous Thrombosis (1998) (28)
Plasma and Platelet von Willebrand Factor Abnormalities in Patients With Uremia: Lack of Correlation With Uremic Bleeding (2001) (28)
Anti-prothrombin antibodies as a potential risk factor of recurrent venous thromboembolism (2004) (28)
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature (2008) (28)
Mutations which Introduce Free Cysteine Residues in the Gla-Domain of Vitamin K Dependent Proteins Result in the Formation of Complexes with α1-Microglobulin (1996) (28)
Effect of grazing and homeopathy on milk production and immunity of Merino derived ewes (2007) (27)
State-of-the-Art Review : Aspirin Seems as Effective as Myelosuppressive Agents in the Prevention of Rethrombosis in Essential Thrombocythemia (1999) (27)
Severe factor X deficiency in pregnancy: case report and review of the literature (2004) (27)
Branch retinal vein occlusion: the pathogenetic role of blood viscosity. (1990) (27)
Chemical composition of pig meat from the genetic type 'Casertana' and its crossbreeds. (2003) (27)
Genetic type, sex, age at slaughter and feeding system effects on carcass and cut composition in lambs (2007) (26)
Detection of B-cell monoclonality in fine needle aspiration by PCR analysis. (1998) (26)
Sex and age as prognostic factors in essential thrombocythemia. (1992) (26)
Pregnancy‐induced worsening of thrombocytopenia in a patient with type IIB von Willebrand's disease (1991) (26)
The Value of Ultrasound Screening for Proximal Vein Thrombosis after Total Hip Arthroplasty (2001) (26)
Avoidance distance in sheep: test-retest reliability and relationship with stockmen attitude (2011) (26)
Hepatosplenic γδ T‐cell lymphoma presenting with immune‐mediated thrombocytopenia and hemolytic anemia (Evans' syndrome) (2002) (25)
Development and validation of a quantitative frame of reference for meat sensory evaluation (2012) (25)
Platelet aggregation and pseudothrombocytopenia induced by 1‐desamino‐8‐D‐arginine vasopressin (DDAVP) in type IIB von Willebrand's disease patient (1990) (25)
Thrombotic Events in Patients with Congenital Prekallikrein Deficiency: A Critical Evaluation of All Reported Cases (2010) (24)
Hereditary heparin cofactor II deficiency and thrombosis: report of six patients belonging to two separate kindreds (1990) (24)
Type 2M von Willebrand disease variant characterized by abnormal von willebrand factor multimerization. (2001) (24)
Childhood stroke associated with familial protein S deficiency (1994) (23)
Crossover electrophoresis (electrosyneresis) visualization of the abnormal factor X (factor X Friuli). (1972) (23)
Fibrinolytic study in plasma and ascitic fluid of cirrhotic patients before and after ascites concentration; reinfusion technique (1985) (23)
Detection and characterization of seven novel protein S (PROS) gene lesions: evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. (1995) (23)
Role of fibrinolytic and clotting parameters in the diagnosis of liver veno-occlusive disease after hematopoietic stem cell transplantation in a pediatric population (2005) (23)
Podolian beef production on pasture and in confinement. (2011) (23)
Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor. (2003) (23)
Second malignancies in patients with essential thrombocythaemia. (2002) (23)
Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception. (1996) (23)
Clinical significance of beta-thromboglobulin in patients with high platelet count. (1984) (23)
Activated Protein C Resistance in Normal and Pre-Eclamptic Pregnancies (2003) (23)
Chemical, physical and sensory properties of meat from pure and crossbred Podolian bulls at different ageing times. (2005) (23)
Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE). (2002) (23)
A new global test for the evaluation of the protein C—protein S system (1996) (22)
The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency (2010) (22)
Type IIB von Willebrand Disease: Role of Qualitative Defects in Atherosclerosis and Endothelial Dysfunction (2007) (22)
Prevalence of anti‐FVIII antibodies in severe haemophilia A patients with inversion of intron 22 (1997) (22)
Time budget, social and ingestive behaviours expressed by native beef cows in Mediterranean conditions (2011) (22)
Factor X assays using chromogenic substrate S-2222. (1980) (22)
Liking of Traditional Cheese and Consumer Willingness to Pay (2014) (22)
Thrombosis-free Surgical Procedures in Severe(Homozygote) Factor XII Deficiency: Report of Four Additional Cases and Literature Review (2004) (22)
Labeling of platelet surface glycoproteins with biotin derivatives. (1992) (22)
FIBRINOLYTIC AND PROTEOLYTIC ACTIVITY IN ACUTE AND CHRONIC LEUKEMIA (1966) (22)
Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias. (1980) (22)
Effects of early maternal separation of lambs and rearing with minimal and maximal human contact on meat quality. (2006) (22)
Venous thrombosis and tissue plasminogen activator release deficiency: a family study (1991) (22)
Hemorheological study in patients with coronary artery disease. (1991) (21)
Sustainability and welfare of Podolian cattle (2005) (21)
Fibronectin and antithrombin as markers of pre-eclampsia in pregnancy. (1996) (21)
Indirect study of thrombopoiesis(TPO, reticulated platelets, glycocalicin)in patients with hereditary macrothrombocytopenia (2000) (21)
Pregnancy-related Recurrent Events in Thrombophilic Women with Previous Venous Thromboembolism (2001) (21)
A dysfunctional factor X (factor X San Giovanni Rotondo) present at homozygous and double heterozygous level: identification of a novel microdeletion (delC556) and missense mutation (Lys(408)-->Asn) in the factor X gene. A study of an Italian family. (2001) (21)
Asymptomatic Homozygous nt 20210 G to A Prothrombin Polymorphism in Two Blood Donors Belonging to Two Different Kindreds (1999) (21)
Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification. (1998) (21)
Familial thrombophila associated with high levels of plasminogen activator inhibitor (1992) (21)
Seasonal Variation in the Incidence of Deep Vein Thrombosis in Patients With Deficiency of Protein C or Protein S (2002) (21)
Hemorrhagic Syndrome in Dogs Induced by Intravenous Thrombin (1966) (21)
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected (2017) (21)
An Immunological Investigation of Hemophilia B with a Tentative Classification of the Disease into Five Variants 1 (1977) (20)
Compound heterozygous protein C deficiency resulting in the presence of only the beta-form of protein C in plasma. (1996) (20)
Re-evaluation of the therapeutic efficacy of DDAVP in type IIB von Willebrand's disease. (1994) (20)
Abnormally large von Willebrand factor multimers in Henoch‐Schönlein purpura (1996) (20)
Isolation and characterization of the factor X Friuli variant. (1989) (20)
Lack of multimer organization of von Willebrand factor in an acquired von Willebrand syndrome (2002) (20)
Common Mutation of Plasminogen Detected in Three Asian Populations by an Amplification Refractory Mutation System and Rapid Automated Capillary Electrophoresis (1999) (20)
Congenital Combined Defects of Factor VII: A Critical Review (2006) (20)
Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era (2011) (20)
Phenotype and genotype expression in pseudohomozygous factor VLEIDEN : the need for phenotype analysis. (1999) (20)
Splenectomy after portal thrombosis in patients with polycythemia vera and essential thrombocythemia. (2002) (20)
Congenital FVII Deficiency and Pulmonary Embolism (2013) (19)
Partial gene deletion in a family with factor X deficiency. (1989) (19)
Ultrasonography of contralateral veins in patients with unilateral deep-vein thrombosis (1998) (19)
Prothrombin Padua I: incomplete activation due to an amino acid substitution at a factor Xa cleavage site. (1994) (19)
Soluble Plasma Thrombomodulin Levels in Patients with Chronic Myeloproliferative Disorder (1999) (19)
Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and –13C>T promoter region in three compound heterozygotes (2008) (19)
Rigidity of red cells in essential hypertension. (1978) (18)
Occurrence of thrombosis in congenital thrombocytopenic disorders: a critical annotation of the literature (2013) (18)
Severe Congenital Factor X Deficiency in 5-Month-Old Child (1970) (18)
Another Family with the Factor VII Padua Clotting Defect (1979) (18)
Platelet Aggregation Induced by Plasma from Type IIB von Willebrand’s Disease Patients Is Associated with an Increase in Cytosolic Ca2+ Concentration (1993) (18)
Antithrombin Padua. I: Impaired heparin binding caused by an Arg47 to his (CGT to CAT) substitution. (1990) (18)
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. (1994) (18)
Fibrinolytic pattern in recurrent spontaneous abortions: No relationship between hypofibrinolysis and anti‐phospholipid antibodies (1994) (18)
Tentative and updated classification of factor X variants. (1986) (18)
In vivo platelet release reaction in patients with heart valve prosthesis. (1980) (17)
Oral contraceptives caused thrombosis in a monoovular twin with protein C deficiency, while the other, without medication, remained asymptomatic. (1992) (17)
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. (1997) (17)
Effect of delivery modalities on the physiologic inhibition system of coagulation of the neonate. (2002) (17)
A common point mutation producing type 1A antithrombin III deficiency: AT129 CGA to TGA (Arg to Stop). (1991) (17)
Hepatosplenic gammadelta T-cell lymphoma presenting with immune-mediated thrombocytopenia and hemolytic anemia (Evans' syndrome). (2002) (17)
Which Assay Is the Most Suitable to Investigate von Willebrand Factor Functional Activity ? (1999) (17)
A new factor X defect (factor X Padua 3): a compound heterozygous between true deficiency (Gly(380)-->Arg) and an abnormality (Ser(334)-->Pro). (2001) (17)
Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. (1983) (17)
Control of Ovulation-Induced Hemoperitoneum by Oral Contraceptives in a Patient with Congenital Hypoprothrombinemia and in Another with Congenital Factor V Deficiency (2008) (17)
Antithrombin III Trento. A 'new' congenital AT III abnormality with a peculiar crossed-immunoelectrophoretic pattern in the absence of heparin. (1984) (17)
Combined hemophilia A and type 2 von Willebrand's disease: defect of both factor VIII level and factor VIII binding capacity of von Willebrand factor. (2001) (17)
Worldwide diffusion of FVII Arg304Gln coagulation defect (FVII Padua) * (2011) (17)
A Founder Effect Is Proposed for Factor XIII B Subunit Deficiency Caused by the Insertion of Triplet AAC in Exon III Encoding the Second Sushi Domain (1998) (17)
Essential Thrombocythemia and Pregnancy: A Report of Six Normal Pregnancies in Five Untreated Patients (1994) (17)
SENSORY PROPERTIES AFFECTING ACCEPTABILITY OF “BRESAOLA” FROM PODOLIAN YOUNG BULLS (2009) (17)
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) (2018) (16)
A large family from Argentina with Prekallikrein deficiency due to a compound heterozygosis (T insertion in intron 7 and Asp558Glu in exon 15): Prekallikrein Cordoba (2010) (16)
Pregnancy and Oral Contraceptives in Congenital Bleeding Disorders of the Vitamin K- Dependent Coagulation Factors (2006) (16)
Rheological and fibrinolytic findings in multiple sclerosis. (1981) (16)
Oral Contraceptives and Venous Thromboembolism: Which Are the Safest Preparations Available? (2002) (16)
A new family with congenital factor XIII deficiency showing a deficit of both subunit A and B. Type I factor XIII deficiency. (1987) (16)
Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor. (1999) (16)
Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies (1999) (16)
Rhinophyma-like cryptococcal infection as an early manifestation of AIDS in a hemophilia B patient. (1990) (16)
Pregnancies and Oral Contraceptive Therapy in Severe (Homozygons) FXII Deficiency: A Study in 12 Patients and Review of the Literature (2004) (16)
Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis. (1999) (16)
Low rate of venous thromboembolism in asymptomatic relatives of probands with factor V Leiden mutation. (1999) (16)
Chronic isolated macrothrombocytopenia with autosomal dominant transmission: a morphological and qualitative platelet disorder (1997) (15)
AN UPDATED CLASSIFICATION OF FACTOR XIII DEFECT (1991) (15)
Recombinant thromboplastin is slightly more sensitive to factor VII Padua than standard thromboplastins of human origin. (1993) (15)
Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease. (1989) (15)
Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin (2012) (15)
Classical Factor X Deficiency (1975) (15)
The use of fluorescence flow cytometry in the characterization of Bernard-Soulier syndrome and Glanzmann's thrombasthenia. (1989) (15)
The release of beta-thromboglobulin and platelet factor 4 during extracorporeal circulation for open heart surgery. (1981) (15)
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis (1991) (15)
Glycocalicin in the diagnosis and management of immune thrombocytopenia (1998) (15)
Letter to the editor: Spurious protein C deficiency due to antiphospholipid antibodies (1991) (15)
Symptomatic Combined Homozygous Factor XII Deficiency and Heterozygous Factor V Leiden (2000) (15)
Prevalence of specific thrombotic accidents in patients with thrombocytosis. (1993) (15)
The effect of ellagic acid on the thrombin-induced hemorrhagic syndrome in the rat. (1966) (15)
Recent progress in the therapeutic management of pre-eclampsia (2004) (14)
Homozygous factor V-deficient patients show resistance to activated protein C whereas heterozygotes do not. (1994) (14)
Cerebral Vascular Accidents in Young Patients with Essential Thrombocythemia: Relation with Other Known Cardiovascular Risk Factors (1998) (14)
Effect of Age on Oral Contraceptive-Induced Venous Thrombosis (2004) (14)
A tentative classification of factor XIII deficiency in two groups. (1977) (14)
Homozygous Patients With the 20210 G to A Prothrombin Polymorphism Remain Often Asymptomatic in Spite of the Presence of Associated Risk Factors (2001) (14)
Heparin, coumarin, protein C, antithrombin, fibrinolysis and other clotting related resistances: old and new concepts in blood coagulation (2017) (14)
Combined hereditary deficiency of factors VII and VIII: a distinct coagulation disorder due to the 'lack' of an autosomal gene controlling factor VII and VIII activation? (1976) (14)
Effects of ticlopidine on blood fibrinogen and blood viscosity in peripheral atherosclerotic disease. (1985) (14)
Acute pancreatitis and deep vein thrombosis associated with HELLP syndrome. (1999) (14)
Mild haemophilia A fails to protect from coronary artery disease: the report of two cases. (1993) (14)
Characterization of Recombinant Human Coagulation Factor XFriuli (1996) (14)
Effect of rearing system and of dietary protein level on leptin, growth, and carcass composition in young Podolian bulls. (2009) (14)
The Relationship between Defective Heparin Cofactor Activities and Thrombotic Phenomena in AT III Abnormalities (1988) (14)
Prevalence of hypertension and its complications in congenital prekallikrein deficiency: analysis of all reported cases and clinical significance (2015) (14)
Ox Brain versus Rabbit Brain Thromboplastin Assays Are the Best Tool for a Preliminary Diagnosis of the Arg304Gln Factor VII Defect (FVII Padua) (2010) (13)
Complex History of the Discovery and Characterization of Congenital Factor X Deficiency (2015) (13)
Influence of the Alu-Repeat I/D Polymorphism in t-PA Gene Intron 8 on the Stimulated t-PA Release After Venous Occlusion (2003) (13)
Splenomegaly as the First Manifestation of Thyroid Cancer Metastases (1997) (13)
Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias (2012) (13)
Venous Thrombosis in Rare or Unusual Sites: A Diagnostic Challenge (2013) (13)
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly. (1980) (13)
Remission in hairy cell leukemia-variant following splenic radiotherapy alone. (1997) (13)
The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril. (1984) (13)
Characterization of polymorphic markers in the von Willebrand factor gene and pseudogene (1990) (13)
Bilateral ileofemoral thrombophlebitis after ten contraceptive pills in a 25-year-old woman with antithrombin III deficiency. (1988) (13)
Increased proportion of giant platelets and platelet distribution width are better indicators of altered platelet homeostasis than mean platelet volume in liver cirrhosis. (1988) (13)
Factor X survival and therapeutic factor X levels in the abnormal factor X (factor X FRIULI) COAGULATION DISORDER. (1974) (13)
Chronic viral hepatitis: a prospective factor against atherosclerosis (2008) (13)
A New Mutation (Arg251 Trp) in the Ca2+ Binding Site of Factor X Protease Domain Appears to be Responsible for the Defect in the Extrinsic Pathway Activation of Factor X Padua (2004) (13)
B non-Hodgkin's lymphoma in a haemophilia patient with idiopathic CD4+ T-lymphocytopenia. (1996) (13)
Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature (2015) (13)
Bernard-Soulier syndrome: diagnosis by an ELISA method using monoclonal antibodies in 2 new unrelated patients. (1986) (12)
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period* (2017) (12)
PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders. (2009) (12)
Effects of low-molecular-weight heparin on platelets as compared with commercial heparin (1984) (12)
Prevalence and patterns of symptomatic thromboembolism in oncohematology. (1998) (12)
The Effect of Anticoagulant Mixtures on BTG and PF4 levels (1981) (12)
Drug-Induced Thrombophilic or Prothrombotic States: An Underestimated Clinical Problem That Involves Both Legal and Illegal Compounds (2017) (12)
The possible value of platelet aggregation studies in patients with increased platelet number (1981) (12)
Prevalence of Antiphospholipid Antibodies and Lupus Anticoagulant in Juvenile Patients with Objectively Documented Deep-vein Thrombosis (1996) (12)
Rare and Unusual Bleeding Manifestations in Congenital Bleeding Disorders (2012) (12)
Clinical significance of surface and internal pools of platelet-associated immunoglobulins in immune thrombocytopenia. (2009) (12)
Antithrombin III Activity and Concentration in Diabetes Mellitus (1985) (12)
Early transfusion of factor VIII/von Willebrand factor concentrates seems to be effective in the treatment of gatrointestinal bleeding in patients with von Willebrand type III disease (2001) (12)
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes (2011) (12)
Identification of anti-platelet autoantibodies by western blot in 45 patients with idiopathic thrombocytopenic purpura (ITP). (1992) (12)
Factor VII Padua defect: the heterozygote population. (1982) (12)
Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates. (1999) (12)
Platelet factor 4 release induced by intravenous administration of heparin. (1985) (12)
Arterial and Venous Thromboses in Patients With Idiopathic (Immunological) Thrombocytopenia (2013) (11)
Association of monoclonal gammopathy and polycythemia vera or essential thrombocythemia: study of a large cohort of patients (2003) (11)
Clotting factors and platelets. Immunofluorescence evidence that fibrinogen and factor VIII are present in human washed platelets, whereas prothrombin complex factors and factor XIII are lacking. (1977) (11)
The Incidence of Thrombotic Manifestations in AT III Abnormalities (1987) (11)
Combined Factor V and Factor VII Deficiency Due to an Independent Segregation of the Two Defects (1999) (11)
Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). (2011) (11)
Heterozygous protein-S deficiency: a study of a large kindred. (1990) (11)
Congenital prothrombin defects: they are not only associated with bleeding but also with thrombosis: a new classification is needed (2018) (11)
Serum neopterin levels in haematological malignancies. (1993) (11)
Congenital deficiency of factor XIII with normal subunit S and lack of subunit A. Report of a new family. (1977) (11)
Long-term use of oral contraceptive therapy in women with the prothrombin 20210 G-A polymorphism without thrombotic complications: a study of 13 women (12 heterozygotes and 1 homozygote). (2001) (11)
Discrepant ratios of arterial versus venous thrombosis in hemophilia A as compared with hemophilia B (2014) (11)
Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency (2013) (11)
Acquired Isolated FVII Deficiency (2016) (11)
Cardiovascular diseases in congenital prekallikrein deficiency: comparison with other chance-associated morbidities (2018) (11)
Coagulation and Fibrinolysis During the First Year of Immunosuppressive Treatment in Renal Transplantation: Correspondence Between Hypercoagulable State and Steroid Therapy (1995) (11)
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard–Soulier syndrome (2012) (11)
Factor X Friuli coagulation disorder. Report of a newly recognized patient and some considerations on the frequency of the disease in the Friuli area. (1976) (10)
State-of-the-Art-Review : Combined Heterozygous Plasminogen Deficiency and Factor V Leiden Defect in the Same Kindred (2000) (10)
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis (2011) (10)
Warfarin treatment during pregnancy: a clinical note. (1979) (10)
Transaminase Elevation in Patients Treated with Unfractionated Heparin or Low Molecular Weight Heparin for Venous Thromboembolism (1998) (10)
A study of platelet function and morphology in a new family with May-Hegglin anomaly. (1980) (10)
Clinical aspects of venous thrombophilia (2002) (10)
Hypertriglyceridemia during long-term interferon-alpha therapy in a series of hematologic patients. (1997) (10)
Conformation sensitive gel electrophoresis for detection of factor X gene mutations. (2002) (10)
Lack of factor XII antigen in factor XII deficiency as determined by electroimmunoassay (1982) (10)
Parahemophilia. A case report. (1971) (10)
Post-polycythemia myeloid metaplasia: experience with a large cohort of patients. (1994) (10)
Abnormal factor X(factor X Friuli) coagulation disorder. (1973) (10)
Prevention of Traumatic Bleeding by Ellagic Acid in Rats.∗ (1965) (10)
Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies. (1969) (10)
Patients with AT III, Protein C or Protein S Defects Show no Associated Hereditary APC-Resistance (1994) (10)
Thrombotic events in severe FXII deficiency in comparison with unaffected family members during a long observation period (2019) (10)
Fibrinolytic behavior in long-standing branch retinal vein occlusion. (1987) (9)
Hemospermia in Patients with Congenital Coagulation Disorders: A Study of Three Cases (2009) (9)
Multiple, relapsing thrombosis in a young man with primary thrombocytosis. (1990) (9)
Symptomatic versus asymptomatic patients in congenital hypoplasminogenemia: a statistical analysis. (1994) (9)
Prothrombin antigen evaluation by means of laser nephelometry in health and disease. (1982) (9)
Long Term Use of Oral Contraceptives Without Thrombosis in Patients with FV Leiden Polymorphism: A Study of 37 Patients (2 Homozygous and 35 Heterozygous) (2004) (9)
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain (2003) (9)
EFFECT OF LOW-DOSE SUBCUTANEOUS HEPARIN ON WHOLE-BLOOD VISCOSITY (1976) (9)
CONGENITAL FACTOR XIII DEFICIENCY: TYPE I AND TYPE II DISEASE (1985) (9)
Unexplained Discrepancies in the Activity—Antigen Ratio in Congenital FX Deficiencies With Defects in the Catalytic Domain (2009) (9)
Abnormal Propeptide Processing Resulting in the Presence of Two Abnormal Species of Protein C in Plasma (2001) (9)
Concurrence of varicose osteo-hypertrophic nevus (Klippel-Trenaunay), visceral angiomatosis and thrombocytopenia (Kasabach-Merrit). A case report. (1968) (9)
Acquired type I von Willebrand's disease in a patient with essential thrombocytosis. (1986) (9)
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A. (1977) (9)
Low Rate of Venous Thromboembolism in Asymptomatic Relatives of Probands with Factor V Leiden Mutation (1999) (9)
Comparable Levels of Activity and Antigen in Factor XII Deficiency: A Study of 21 Homozygotes and 58 Heterozygotes (2005) (9)
Haematological complications in polycythaemia vera and thrombocythaemia patients treated with radiophosphorus (32P). (1990) (9)
Factors which may influence coping with disease in haemophilia patients (2004) (9)
Clearance and In Vivo Release by Heparin of Human Platelet Factor 4 (PF4) in the Rabbit (1984) (9)
Unusual thrombotic‐like retinopathy (Coats' disease) associated with congenital plasminogen deficiency type I (1993) (9)
Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies (2016) (9)
Congenital hypoproconvertinemia (factor VII deficiency). A report of two cases belonging to two different kindreds. (1973) (9)
Different Cross-Over Electrophoretic Mobility of Factor Friuli X and Coumarin-induced Abnormal Factor X (1972) (9)
Changing Features of Proximal Vein Thrombosis Over Time (1994) (8)
Increased factor VIII/vWf levels in patients with reduced platelet number (1987) (8)
Rectus muscle sheath haematoma in a patient with congenital FX deficiency and in another with congenital FVII deficiency (2010) (8)
Normal factor 8 antigen level in combined congenital deficiency of factor V and factor VIII. (1974) (8)
Recurrent thromboembolism in fertile women with venous thrombosis: incidence and risk factors (2003) (8)
Protein C, factor VII and prothrombin time as early markers of liver function recovery or failure after liver transplantation (1993) (8)
The significance of thrombocytosis in old age. (1987) (8)
Prevalence of bleeding manifestations in 128 heterozygotes for Factor X deficiency, mainly for FX Friuli, matched versus 128 unaffected family members, during a long sequential observation period (23.5 years) (2016) (8)
Patients with APC Resistance Compared with Those with Other Clotting Inhibitor Deficiencies Show Later Onset of Venous Thrombosis During Oral Contraception (1995) (8)
Tentative Guidelines and Practical Suggestions to Avoid Venous Thromboembolism During Oral Contraceptive Therapy (2002) (8)
State-of-the-Art Review: Low Incidence of Venous Thrombosis in Homozygous Patients with NT 20210 G to a Prothrombin Polymorphism (1999) (8)
Inhibitory Effect of Prostacyclin and Nitroprusside on Type IIB von Willebrand Factor-promoted Platelet Activation (1996) (8)
The hereditary thrombosis (1992) (8)
Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients: effect of hyperinsulinemia. (1997) (8)
Rebuttal: Factor XII levels, factor XII 46 C>T polymorphism and venous thrombosis: a word of caution is needed (2004) (8)
Acute superficial phlebitis in a patient with hemophilia A. Probably an iatrogenic effect. (1972) (8)
Increased Prevalence of Reported Cases of Congenital Prekallikrein Deficiency Among African Americans as Compared With the General Population of the United States (2020) (8)
Different genotypes are responsible for the normal Russell viper venom assays seen in some cases of congenital factor X deficiency (2008) (8)
Long-term safety outcomes of prekallikrein (Fletcher factor) deficiency: A systematic literature review of case reports. (2020) (8)
Eating Quality of Seasoned Ham in Eight Pig Genetic Types (1987) (8)
The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5 (2014) (8)
Atherosclerosis and Secondary Deep Vein Thrombosis: A Difficult Correlation (2003) (8)
Wells PS, Hirsh J, Anderson DR, et al: Accuracy of clinical assessment of deep-vein thrombosis (1995) (8)
Factor VIII immunological assay. An evaluation of several methods using whole plasma (1974) (8)
Effect of recombinant-tissue plasminogen activator, low molecular weight urokinase and unfractionated heparin on platelet aggregation. (1993) (8)
Antithrombin III Padua 2: a single base substitution in exon 2 detected with PCR and direct genomic sequencing. (1990) (8)
Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke? (2008) (8)
The effect of a single course of alpha-2B-interferon in patients with HIV-related and chronic idiopathic immune thrombocytopenia. (1993) (8)
A DIC-like picture on plasma and ascitic fluid of cirrhotic patients (1988) (8)
Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf. (1986) (8)
Serum of normal subjects contains IgG with antibody-like specificity for phospholipids. (1984) (8)
Retinal central artery occlusion in a young woman after ten days of a drospirenone-containing oral contraceptive (Yasmin) (2007) (8)
Venous thromboembolism, fetal loss and preeclampsia in pregnant women with congenital thrombophilia. (2001) (8)
Clotting changes in borderline hypertension. (1987) (8)
Prothrombin: Another Clotting Factor After FV That Is Involved Both in Bleeding and Thrombosis (2018) (8)
Factor X Friuli coagulation disorder (1973) (7)
Failure of soluble fibrin polymers in the diagnosis of clinically suspected deep venous thrombosis. (1999) (7)
Platelet factor 4 (PF4) and heparin released platelet factor 4 (HR-PF4) in diabetes mellitus. Effect of the duration of the disease. (1986) (7)
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family (2000) (7)
Congenital Afibrinogenemia (1971) (7)
Heparins and Release (1980) (7)
Intra-cardial thrombosis with systemic and pulmonary embolism as main symptoms in a patient with protein S deficiency. (1992) (7)
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease (2014) (7)
True Congenital Prothrombin Deficiency Due to a ‘New’ Mutation in the Pre-Propeptide (ARG-39 GLN) (2008) (7)
APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems. (2000) (7)
Congenital Thrombophilia and Intracardiac Thrombosis: Probably an Underdiagnosed Event (2013) (7)
The lack of ties between north-eastern Italy and African-Americans suggest a multi-founder effect for FVII Padua (Arg304Gln) disorder. (2010) (7)
Clinical and laboratoristic remission after cryosupernatant plasma exchange in thrombotic thrombocytopenic purpura. (1998) (7)
Bleeding manifestations in heterozygotes with prothrombin deficiency or abnormalities vs. unaffected family members as observed during a long follow-up study (2017) (7)
A structure–function analysis in patients with prekallikrein deficiency (2018) (7)
Emphasis on congenital conditions predisposing to thrombosis should not make us disregard the importance of acquired factors. (1998) (7)
State-of-the-Art Review : G to A 20210 Prothrombin Polymorphism and Venous Thrombosis: Simple Association or Causal Relationship? (2000) (7)
It is not sure yet whether the nt 20210 G to A prothrombin polymorphism represents a cause of familial venous thrombophilia. (1999) (7)
Tissue factor pathway inhibitor levels in patients with homocystinuria. (2000) (7)
Unusual longevity in a patient with factor X Friuli coagulation disorder (2005) (7)
The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain (2009) (7)
Lack of PIVKA effect in the abnormal factor X (factor X Friuli) coagulation disorder. (1972) (7)
Organic meat: Market development and consumer willingness to pay (2011) (7)
Biotin-avidin immobilization of platelet glycoproteins (BAIPG): a new capture assay for the detection of anti-platelet antibodies. (1995) (7)
Primary breast lymphoma. (1998) (7)
Myocardial Infarctions and Other Acute Coronary Syndromes in Rare Congenital Bleeding Disorders (2015) (7)
Activity Budgets and Forage Selection of Podolian Cattle, a Semiwild Bovine Breed (2011) (7)
Portal vein thrombosis in a patient with severe haemophilia A and post-hepatitis liver cirrhosis. (1991) (7)
Fibrinolysis and proteolysis in patients with lymphoma. (1966) (7)
Adrenaline potentiates type 2B von Willebrand factor-induced activation of human platelets by enhancing both the formation and action of thromboxanes. (2000) (7)
FACTOR VIII ANTIGEN PRE-PEAK (1980) (7)
The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII (2015) (7)
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. (1993) (6)
Appearance, consumer liking and preferences of Lucanian 'Soppressata' salami. (2020) (6)
The impact of blood coagulability on atherosclerosis and cardiovascular disease: a rebuttal (2013) (6)
Incidence of thrombocytosis in lymphomas. (1992) (6)
FXII deficiency is neither a cause of thrombosis nor a protection from thrombosis. (2005) (6)
Relevance of Inherited Risk Factors in Young Patients with Deep-Vein Thrombosis (1996) (6)
Discrepancies between clotting and chromogenic assays in congenital coagulation disorders: the hemostatic coin has only one face, chromogenic substrates many. (2009) (6)
Antithrombin III deficiency: a report of 14 cases belonging to three different kindreds. (1985) (6)
A cluster of factor XI‐deficient patients due to a new mutation (Ile 436 Lys) in northeastern Italy * (2012) (6)
[A new congenital hemorrhagic coagulation disorder probably due to the presence of an abnormal factor X. Preliminary study]. (1969) (6)
The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified (2009) (6)
About the significance or the insignificance of the factor XII C46T polymorphism: a rebuttal (2007) (6)
Thrombotic Manifestations in Plasminogen Deficiency and in Plasminogen Abnormalities (1988) (6)
Beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) release by adenosine diphosphate (ADP) contact with native whole blood. (1985) (6)
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). (1985) (6)
Are platelet factor 4 and beta-thromboglobulin markers of cardiovascular disorders? (1984) (6)
The prevalence of AIDS, AIDS related complex and HIV seropositivity in a large population of patients with congenital clotting disorders. (1988) (6)
New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice (2017) (6)
Low Rate of Warfarin-related Major Bleeding in Patients with Recurrent Venous Thromboembolism (1999) (6)
Which tests are most useful in distinguishing between reactive thrombocytosis and the thrombocytosis of myeloproliferative disease? (2008) (6)
Hemophilia B+ or BM. first case reported in Italy (1973) (6)
Congenital combined factor V and factor VIII deficiency in a male born from a brother-sister incest (2005) (6)
CROSSED IMMUNOELECTROPHORESIS IN THE STUDY OF ABNORMAL ANTITHROMBINS III: BEHAVIOUR OF AT III TRENTO (1983) (6)
Combined haemophilia A and type I von Willebrand's disease: a family study including an evaluation of the effects of DDAVP infusion. (1993) (6)
The Value of βTG/PF4 Ratio in Patients with High Platelet Count (1985) (6)
Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation† (2016) (6)
Evaluation of platelet function in postsplenectomy thrombocytosis. (1987) (6)
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study. (2019) (6)
About the rarity of haemoptysis in congenital bleeding disorders. A report of five cases (1) (2009) (6)
DDAVP infusion in haemophilia A carriers: different behaviour of plasma factor VIII and von Willebrand factor. (1996) (6)
Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis. (1981) (6)
A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance. (1995) (6)
Treatment of refractory ITP with extracorporeal immunoadsorption over a protein-A sepharose column: a report of two cases. (2000) (6)
Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents. (1999) (6)
Heparin-Induced Thrombocytopenia: Prevalence in a Large Cohort of Patients and Confirmed Role of PF4/Heparin Complex as the Main Antigen for Antibodies (1997) (6)
Factor X Friuli coagulation disorder. The demise of the index patient. (1975) (6)
The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2). (1984) (6)
Combined inherited protein S and heparin co-factor II deficiency in a patient with upper limb thrombosis: a family study. (1992) (5)
The Significance or Nonsignificance of the G to A 20210 Prothrombin Polymorphism (2000) (5)
The management of feto-maternal alloimmune thrombocytopenia: Report of three cases (2006) (5)
Thrombocytosis in young people: Evaluation of 57 cases diagnosed before the age of 40 (1990) (5)
A Coagulation Study in Patients with Neuroblastoma (1967) (5)
Prothrombin level in coumarin-treated patients. A peculiar effect observed in a one-stage system using certain substrates. (1974) (5)
Factor V antigen levels in APC resistance, in factor V deficiency and in combined APC resistance and factor V deficiency (pseudohomozygosis for APC resistance). (1997) (5)
Haemolytic uraemic syndrome during treatment with ketorolac trometamol. (1993) (5)
Eating quality of beef from free-range and confined Podolian young bulls. (2013) (5)
Decrease of fibrinogen in patients with peripheral atherosclerotic disease by ticlopidine. (1991) (5)
Influence of storage conditions and age at slaughter on lipid oxidation and fatty acid profiles of apulian lamb (2001) (5)
The Effect of Fibrinolysis Inhibitors on the Ellagic Acid Activation of Hageman Factor in the Dog (1971) (5)
Two novel (R(−11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds (1996) (5)
Idiopathic Versus Secondary Thrombosis as a Predictive Marker of Occult Malignancy (1998) (5)
First case in Italy of fatal AIDS in a hemophiliac. (1986) (5)
Prethrombotic, prothrombotic, thrombophilic states, hypercoagulable state, thrombophilia etc.: semantics should be respected even in medical papers (2017) (5)
Classical factor X deficiency. Report of a further case. (1975) (5)
Hemophilia B with associated factor VII deficiency: A distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen (1980) (5)
A family with heterozygous factor X friuli defect outside friuli (1983) (5)
Prothrombotic Activity of Oral Contraceptives in Patients With Congenital Thrombophilia Varies With the Defect (2001) (5)
Diagnosis of recurrent deep vein thrombosis. (2001) (5)
Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis. (1988) (5)
STUDIES IN IODINE METABOLISM. 3. THREE-POOL SYSTEMS OF EXTRATHYROIDAL THYROXINE KINETICS. (1965) (5)
Further studies on clotting changes in patients with cerebral sinus thrombosis. A case with thrombosis of right transverse sinus. (1981) (5)
Additional Evidence against the Presence of Inhibitors in Vit. K Deficiency and in Coumarin-Treated Patients (1981) (5)
Difficulties in the Mutation Analysis of Plasminogen Gene: A Study in Two Patients with Ligneous Conjunctivitis (2006) (5)
Below-knee elastic compression stockings for prevention of the post-thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study (2003) (5)
Greater decrease of fibrinogen as compared to antithrombin III in L-asparaginase treated leukemia patients. (1986) (5)
Failure of two anti-platelet drugs (indobufen and dipyridamole) to improve thrombocytopenia in liver cirrhosis. (1987) (5)
Thrombocytopenia secondary to oxprenolol, a beta-blocking agent. (1982) (5)
A family with factor X deficiency from Argentina: a compound heterozygosis because of the combination of a new mutation (Gln138Arg) with an already known one (Glu350Lys) (2016) (5)
A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand factor oligomers in the presence of all size multimers. (1994) (5)
The effect of heparin on the interaction of factor VIII and human platelets in vitro. (1977) (5)
Excess of factor X antigen versus clotting counterpart in coumarin treated patients as determined by an Elisa method. (1985) (5)
A Role for Platelet-Derived Growth Factor in Drug-Induced Chronic Ergotism? (1995) (5)
Antiplatelet glycoprotein autoantibodies in patients with autoimmune diseases with and without thrombocytopenia (1996) (5)
Platelet Serotonin and Platelet Aggregation in the Differential Diagnosis of Thrombocytosis (1982) (5)
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter. (1977) (4)
Disappearance of human platelet factor 4 (PF4) in rabbits: does an immediate component exist? (1985) (4)
Dilution curve studies in prothrombin complex factors deficiencies and abnormalities (1974) (4)
Exogenous heparin reduces soluble plasma thrombomodulin levels. (1997) (4)
A statistical analysis of some thromboelastographic parameters in normal subjects. (1983) (4)
First report of centroblastic lymphoma in a human immunodeficiency virus-positive patient with a rare congenital coagulation disorder (factor X Friuli). (1991) (4)
Report of the Second Patient with a Homozygous FVII Padua (Arg304GIn) Defect in Northern Argentina (2018) (4)
Therapeutic Thrombocytapheresis in a Case of Thrombocytosis (1981) (4)
Evidence against the presence of "inhibitors" in coumarin treated patients. (1978) (4)
Essential thrombocythemia following polycythemia vera: an unusual sequence. (1996) (4)
Effect of heparin and aspirin on platelet and clotting activation during leukapheresis (1985) (4)
Demonstration that venous occlusion fails to release von Willebrand factor multimers. (1995) (4)
Frequent association of factor VII defects with other clotting disorders. (1992) (4)
DDAVP effect on factor XII activity levels. (1989) (4)
Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state. (1979) (4)
Familial thrombocythemia and/or thrombocytosis--apparently a rare disorder. (1987) (4)
Artificial rearing and intramuscular fatty acid composition of unweaned lambs (2003) (4)
The effect of several viper venoms on prothrombin Padua (1975) (4)
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickens. (1980) (4)
Myorheological, Chemical and Colour Characteristics of Meat in Water Buffalo and Bovine Calves Slaughtered at 20, 28 and 36 Weeks (1978) (4)
A paradoxical side-effect of antiaggregating treatment with ticlopidine: the Moschowitz syndrome. (1999) (4)
Pyoderma gangrenosum associated with idiopathic myelofibrosis. Case history. (1993) (4)
A report of a case of congenital afibrinogenemia (2005) (4)
Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state. (1976) (4)
Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients. (2013) (4)
Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity. (1999) (4)
Further studies on factor VII padua defect: the report of the fourth homozygous patient from the same valley (1982) (4)
[Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)]. (1979) (4)
Prothrombin Molise I: documentation of a second incidence of replacement of a critical Arg near the active site. (1995) (4)
Autosomal dominant macrothrombocytopenia with ineffective thrombopoiesis. (2002) (4)
Are platelet factor 4 and β-thromboglobulin markers of cardiovascular disorders? (1984) (4)
Low molecular weight heparins in clinical practice: unsolved or partially solved problems. (1998) (4)
Factor X level in coumarin treated patients and in factor X deficiency as assayed with different techniques (1972) (4)
Thrombocytosis and Recurrent Hepatic Outflow Obstruction (Budd-Chiari Syndrome) After Successful Thrombolysis: Case Report and Literature Review (2002) (4)
[Erythrocyte filterability and relative viscosity in liver cirrhosis and chronic hepatitis]. (1989) (4)
ProC Global: A New Automated Screening Assay for the Evaluation of Total Function of the Protein C System (2001) (4)
TENDERNESS, pH AND ACCEPTABILITY OF MEAT FROM PODOLIAN AND LIMOUSINE × PODOLIAN YOUNG BULLS (2008) (4)
Increased Whole Blood Viscosity on Cooling in a Patient with Cold Hemoagglutinin Disease (1976) (4)
Changes in Prescription Patterns of Oral Contraceptives in a Northern Italian Province: Relation With Venous Thromboembolism (2003) (4)
CD25‐negative hairy cell leukaemia: Intracytoplasmic detection of Tac antigen and interferon‐induced surface expression (1995) (4)
A frequent factor XII gene mutation in Hageman trait (1988) (4)
Thrombocytopenia in liver cirrhosis complicated by variceal haemorrhage: lack of increase in platelet count after spleno renal distal shunt. (1987) (4)
Bleeding manifestations apparently unrelated to coagulation or other organic disorders: A tentative classification and diagnostic clues (2014) (4)
The report of an Italian family with heterozygous protein C deficiency. (1988) (4)
Factor X Friuli coagulation disorder. First report of a patient born in Friuli after the description of the disease. (1973) (4)
Myeloproliferative disease in patients with a history of multiple blood donations: a report of 8 cases. (1994) (4)
Decreased platelet mitogenic activity in patients with diabetes mellitus. (1991) (4)
ASPIRIN AND BLEEDING-TIME (1979) (4)
[The genetics of thrombosis]. (1991) (3)
Recombinant thromboplastin inhibition assay for the detection of lupus anticoagulant. (1995) (3)
Report of the fifth homozygous patient with factor VII Padua defect. (1983) (3)
Diagnosis and Follow-up of Thrombotic Thrombocytopenic Purpura by Means of von Willebrand Factor Collagen Binding Assay (2006) (3)
Platelet-specific proteins in patients with transient ischemic attacks (1983) (3)
The action of ellagic acid on the coagulation mechanism and experimental and clinical bleeding. (1967) (3)
Apparent decrease of "inhibition" in the dilution curve system with the increase of anticoagulation. A paradox that is against the presence of inhibitors in coumarin treated patients. (1977) (3)
A family with an abnormal protein C and a thrombotic tendency. (1993) (3)
Congenital factor VII deficiency a case report (1973) (3)
Contact phase of coagulation in diabetes mellitus after aspirin administration. (1985) (3)
Atopic dermatitis and allergic diseases with thrombocytosis: a possible link. (1995) (3)
A tentative classification of AT III congenital abnormalities. (1987) (3)
Idiopathic Deep Vein Thrombosis and Subsequent Cancer: Suggestions for a Patient-Oriented and Practical Approach (2001) (3)
Spontaneous Versus Secondary Thrombosis in Congenital Heterozygous Plasminogen Deficiency (1993) (3)
The congenital variants of the prothrombin complex factors. (1980) (3)
Antithrombin III (AT III) Padua2: A “New” congenital abnormality with defective heparin co-factor activities but no thrombotic disease (1983) (3)
The Significance of Plasma and/or Platelet Activated Products After Apheresis Procedures (1983) (3)
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery. (2019) (3)
[Use and misuse of hospital admission in a department of medicine in Padua]. (1996) (3)
Thrombophilias in pregnancy and their role in preeclampsia (2007) (3)
Factor X friuli: An immunological study in plasma and in serum using several methods (1975) (3)
Polycythemia vera and essential thrombocythemia with monoclonal gammopathy: experience of a single institution. (2001) (3)
Kallikrein and prekallikrein levels in a large number of congenital clotting deficiencies and abnormalities. (1982) (3)
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations (2016) (3)
Full dose dipyridamole significantly improves thrombocytopenia in liver cirrhosis (1987) (3)
Mild factor VII deficiency due to heterozygosis is not associated with a bleeding tendency. (2005) (3)
Marked but transitory elevation of hepatic transaminases after subcutaneous calcium heparin administration. (1994) (3)
Intra-Atrial Thrombosis and Homozygous Factor V Leiden Mutation (1997) (3)
Proposal of a Flow Chart for Thrombosis-Free Oral Contraceptive Therapy (2003) (3)
Normal pregnancy and delivery in essential thrombocythemia even without interferon therapy (1994) (3)
Prothrombin Evaluation as Obtained by Kinetics Studies of Antigen-Antibody Reaction in a Laser Nephelometer (1984) (3)
Confirmation of the Value of a Modified Long-distance Polymerase Chain Reaction in the Detection of Inversion Intron 22 in Severe Hemophilia A: A Technical Note (2005) (3)
Prolonged oral contraceptive therapy in a woman with an antithrombin III abnormality involving heparin binding (type IIc) without thromboembolic complications. (1994) (3)
Congenital hypoprothrombinemia. Case report. (1970) (3)
Heparin-induced thrombocytopenia - prevalence in 236 patients and evidence that complex pf4 - heparin is the main antigen for the antibodies (1995) (3)
Fibrinolytic effects of defibrotide in atherosclerotic patients. (1991) (3)
Failure of L - Asparaginase to Decrease Protein C - A Possible Rebound Phenomenon (1986) (3)
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V‐related disorders (2001) (3)
SHELF LIFE OF MEAT FROM PODOLIAN YOUNG BULLS IN RELATION TO THE AGING METHOD (2007) (3)
Conformational Changes of Congenital FVII Variants with Defective Binding to Tissue Factor ARG304GLN (FVII Padua), ARG 304TRP (FVII Nagoya) and ARG79GLN (FVII Shinjo or Tondabayashi) (2013) (3)
A Large Deletion due to a New Mutation (Intron 13/Exon 23) in a Sporadic Case of Severe Hemophilia A (2004) (3)
Anticoagulant Treatment in Patients with Cancer and Venous Thrombosis Recurrent Venous Thromboembolism and Bleeding Complications During (2013) (3)
Integral viscosity: a useful parameter in evaluating whole blood and plasma viscosities in health and disease. (1982) (3)
Variability of plasma viscosity in monoclonal IgM gammopathies. (1990) (3)
Selection of both normal and bleeding patients is indicated before desmopressin administration (2005) (3)
Immunosuppression due to MACOP-B does not seem to cure the antiphospholipid syndrome. (1999) (3)
Anti-hepatitis C virus serology in patients affected with congenital coagulation defects: a comparative study using three second generation ELISA tests. (1994) (3)
Basic, laboratory and clinical aspects of thromboembolic diseases. (1997) (3)
Factor VII survival studies in factor VII Padua abnormality. (1980) (3)
Platelet adhesiveness and aggregation in congenital afibrinogenemia (1975) (3)
A COMMENT ON THE CLASSIFICATION OF FACTOR VII VARIANTS (1982) (3)
Factor VII and haemostasis: interaction between abnormal factors VII and tissue thromboplastins. (1990) (3)
Two novel (R(-11)C; T394D) and two repeat missense mutations in the protein C gene associated with venous thrombosis in six kindreds. (1996) (3)
Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex. (1977) (2)
About the Cost of Opposing the Coumarin-lnhibitor Theory (1983) (2)
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred. (1995) (2)
Disappearance of ellagic acid induced hyper-coagulability in the dog after trasylol administration. (1973) (2)
Factor VIII/von Willebrand factor abnormalities during L-asparaginase treatment in patients with acute lymphoblastic leukemia. (1988) (2)
The effect of increasing heparin doses and of heparinoid on platelet factor 4 (PF4) release in normal subjects. (1984) (2)
HIV infection and polycythemia vera: a relationship worth pursuing? (1993) (2)
Normal platelet adhesiveness and aggregation in congenital PTA or Hageman factor deficiency. (1980) (2)
[Ellagic acid and hemostasis]. (1969) (2)
Factor X antigen evaluation by means of a laser nephelometer in health and disease. (1985) (2)
Factor XII activation after DDAVP. (1990) (2)
Platelet aggregation and adhesiveness in classical factor X deficiency and in the abnormal factor X (factor X Friuli) coagulation disorder. (1976) (2)
The effect of different doses of 32P in the treatment of primary thrombocytosis. (1985) (2)
Factor X Friuli Coagulation Disorder: Almost 50 Years Later (2018) (2)
Dilution curves studies in coumarin plasmas and in artificially depleted abnormal control plasmas (1974) (2)
Cardiovascular and hormonal responses to DDAVP before and after β‐blockade in patients with mild essential hypertension (1988) (2)
Blood viscosity studies in native and reconstituted polycythemic blood. (1984) (2)
Effect of captopril on inactive renin and contact phase of coagulation system. (1982) (2)
Protein S deficiency and pregnancy: is there a case for ylaxis? (1997) (2)
Acceptability and intramuscular collagen properties of Podolian beef as affected by ageing (2009) (2)
Myopathy with tubular aggregates and hypertrophic cardiomyopathy in a patient with type IIA von Willebrand disease. (1996) (2)
Mutations are no substitutes for clotting, chromogenic and immunological assays in patients with congenital prothrombin deficiency (2008) (2)
Combined deficiency of factor V and factor VIII. A report of another case (1976) (2)
A microplate enzyme-linked immunospecific assay (ELISA) detecting unbound anti-platelet antibodies. (1984) (2)
Erythrocyte Na+-Li+ countertransport and blood viscosity in arterial hypertension (1986) (2)
Ischemic Strokes in Congenital Bleeding Disorders: Comparison with Myocardial Infarction and other Acute Coronary Syndromes. (2016) (2)
Fibrinolytic effect of a particular glycosaminoglycan (endoglycan) per os on normals and in patients with chronic artery disease. (1990) (2)
The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin. (1976) (2)
Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin. (1984) (2)
Immunohistochemical localization of factor X-like antigen in pancreatic islets and their tumours (2005) (2)
Type I Plasminogen Deficiency Should Probably Be Included Among Familial Thrombophilias (1997) (2)
The Prevalence of HTLV-III and HTLV-I Antibodies in Serum of Hemophiliacs (1985) (2)
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. (2008) (2)
Molecular basis of protein C deficiency in five patients with thrombophilia. (1993) (2)
Residual Factor VII in Thromboplastin Preparations (1978) (2)
Immunofluorescent evaluation of platelet alpha-1-antitrypsin and alpha-2-macroglobulin. (1978) (2)
Lack of Inhibitors in Coumarin Plasma (1982) (2)
About the Significance or Insignificance of Coumarin-Induced Pre-Factors (1980) (2)
Effect of ageing on meat sensory properties of Podolian bulls [Italy] (2001) (2)
[Hemophilia BM (abnormal factor IX in coagulation disorder) (author's transl)]. (1974) (2)
Two Methods for Intraplatelet Serotonin Evaluation: Their Use in Thrombocytosis (1997) (2)
Decrease of Normotest/Thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation (1976) (2)
Heterozygous Protein C Deficiency Associated with Multiple Congenital Hemangiomas—A Case Report (1991) (2)
Tissue Plasminogen Activator (t-PA) Is Not Present in Human Platelets (1995) (2)
Clotting changes in two patients with longitudinal sinus thrombosis. (1980) (2)
Perinatal Intracranial Hemorrhage as First Manifestation of Congenital Hypofibrinogenemia (1996) (2)
Discrepancies between clotting and amidolytic assay in congenital clotting disorders. (1990) (2)
Platelet adhesiveness and aggregation in combined factor V and factor VIII deficiency and in combined factor VII and factor VIII deficiency. (1977) (2)
Smooth muscle autoantibodies in normal rabbit sera. Cross-reaction with human platelets as demonstrated by immunofluorescence. (1977) (2)
Increased number of pseudodrumsticks in neutrophils and large platelets. A "new' congenital leukocyte and platelet morphological abnormality. (1980) (2)
Viper venoms and coumarin-induced prothrombin. A comparison of several one-stage methods employing three different venoms as thromboplastins (1976) (2)
Similarities and discrepancies in homozygous factor VII defects due to mutations in the region of residues Met298 to Cys310 (exon 8) in the catalytic domain of factor VII. (2011) (2)
Oral contraceptive therapy causes an increased and not a decreased resistance to APC. (1995) (2)
A critical evaluation of the available methods for the determination of factor VIII von Willebrand. (1986) (2)
Associated von Willebrand disease as a possible cause of lack of thrombosis in an AT III abnormality (AT III Trento) (2004) (2)
Are oral contraceptives a more important risk factor than pregnancy in women with congenital antithrombin III deficiency? (1993) (2)
Qualitative characteristics of meat in lambs born from ewes subjected to hormonal synchronization of oestrus. (1980) (2)
Identification of antiplatelet antibodies in patients with autoimmune thrombocytopenia by western-blot - presence of antibodies to internal platelet epitopes (1991) (2)
Isolated Iliac Vein Thrombosis During Oral Contraceptive Therapy in Three "Normal" Women (1997) (2)
Immunohistochemical identification of factor X-like antigen in the A cells of the normal human pancreas (1982) (2)
Pitfalls of protein C assays in patients with activated protein C resistance. (1996) (2)
The high prevalence of Prekallikrein deficiency among African Americans deserves further studies (2020) (2)
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosis. (1991) (2)
Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders. (1994) (2)
Hemorrhagic varicella in parahemophilia (1972) (2)
Microheterogeneity of antithrombin III: effect of single amino acid substitutions and relationship with functional abnormalities (1994) (2)
Bleeding as a cause of death in HIV-seropositive patients with congenital clotting disorders. (1993) (2)
Familial Association of Hypoplasminogenemia and Heterozygous Factor V Deficiency (1999) (2)
Incidence, significance, and subtypes of hemophilia BM in a large population of hemophilia B patients (2004) (2)
75Se-methionine platelet survival studies: a proposal for a mathematical correction of the curve. (1982) (2)
Lack of antiplatelet activity of the new coumarin derivative 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy- carboxylmethoxycoumarin under in vivo conditions in man. (1986) (2)
Behavior of several one-stage prothrombin time derivative tests in the abnormal factor X (factor X Friuli) coagulation disorder. (1975) (2)
Diagnostic Value of the Thrombotest Dilution Curve (1977) (1)
Prevalence of HIV infection in a cohort of patients with congenital coagulation defects of the prothrombin complex factors. (1991) (1)
Differences between normal antithrombin III and antithrombin III Padua as determined by laser nephelometry. (1982) (1)
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance (2019) (1)
The effect of heparin on platelet aggregation by common inductors and by ristocetin in congenital bleeding disorders due to factor VIII or fibrinogen defects (1975) (1)
Rheological and clotting changes in the immediate post-myocardial infarction period. (1981) (1)
Anticardiolipin antibodies, functional protein S deficiency, and fetal loss (1995) (1)
The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer. (2014) (1)
Study on a new chromogenic substrate for the prothrombin time determination. (1987) (1)
First experience with a new assay for activity determination of protein S (1994) (1)
[Reserpine and thyroid function. Research with I-131]. (1959) (1)
Hemorrhagic follicular cyst of the left ovary. An unusual complication of anticoagulant treatment. (1981) (1)
Mutations Seen in Families with Factor X Deficiency Composed of Only Heterozygous Patients who Present a Bleeding Tendency (2018) (1)
Identification of an 18 basepair deletion in the PAI-1 gene promoter region in a family with thrombotic disease (1997) (1)
Hereditary and acquired thrombophilia. (1994) (1)
Failure of ellagic acid to affect platelet aggregation in normal and in factor XII deficient plasma (1975) (1)
DDAVP infusion: a possible useful tool in the diagnosis of the haemophilia A carrier state. (1991) (1)
The Effect of Heparins on Platelet Release Reaction (1983) (1)
Failure of sulphinpyrazone to affect platelet survival in patients with rheumatic heart valvular disease: a double blind study using 75Se-methionine labeled platelets. (1983) (1)
Factor V variants, activated protein C resistance and venous thromboembolism. (1998) (1)
In vitro and in vivo effects of ditazol on human platelets malonylaldehyde (MDA) production. (1981) (1)
Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease. (1992) (1)
Further studies on factor IX antigen in hemophilia B (1978) (1)
The biological inertia of coumarin-induced pre-factors (so called PIVKAs) (1991) (1)
The importance of serial immunoglobulin evaluations in HIV-seropositive haemophiliacs. (1993) (1)
The Release of Platelet Factor 4 (PF4) Induced by Heparin and Related Glycosaminoglycans (GAGs) (1984) (1)
The incidence of venous thromboembolism in asymptomatic carriers of antithrombin, protein C or protein S: a prospective cohort study. (1999) (1)
Detection of platelet-reactive antibodies by a new ELISA method based on the interaction of biotinylated platelets antigens with streptavidin-coated microtiter plates (1994) (1)
Anticardiolipin Antibodies in Hemophiliac and Nonhemophiliac Patients with Chronic Hepatitis C (1998) (1)
A comment on congenital prothrombin abnormalities associated with thrombosis but not with bleeding (2020) (1)
Different organization of von Willebrand factor oligomers in type-2A and -2B von Willebrand disease variants: effects of DDAVP infusion and protease inhibitors (1995) (1)
Diagnosis of FVII Padua (Arg304Gln) by means of simple clotting tests. (2010) (1)
Influence of Blood Platelets on Fibrinolysis in Acute and Chronic Leukemia. (1966) (1)
Dental extraction in congenital hemorrhagic patients. (1986) (1)
Immunology of Factor X (1974) (1)
Decreased thrombotic mortality and morbidity after valvular cardiac surgery as a consequence of adequate coumarin anticoagulation. A retrospective study in 516 patients. (1978) (1)
[Effects of sodium beta-benzalbutyrate on platelet adhesion and aggregation. Study on normal subjects and coronary patients]. (1976) (1)
Factor V Leiden (Activated Protein C Resistance) Versus Factor V Deficiency in Padua, Italy (1998) (1)
Matters arising (1982) (1)
Thrombocytopenia in HIV-infected hemophiliacs. (1989) (1)
No change of whole blood of plasma viscosity in cardiac patients after subcutaneous calcium heparin. (1978) (1)
Prevalence of Bleeding as Cause of Death in HIV‐Seropositive Patients with Congenital Clotting Disorders (1992) (1)
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases (2014) (1)
The effect of low-dose estroprogestinic preparations on prothrombin complex factors: No significant increase after an 8-month trial (1985) (1)
TYPE I PADUA: A NEW VARIANT OF VON WILLEBRAND'S DISEASE (1992) (1)
The effect of certain antiplatelet drugs on in vitro malonylaldehyde (MDA) production. (1979) (1)
Alpha-interferon treatment of hairy cell leukemia and associated monoclonal large granular lymphocyte proliferation. (1992) (1)
Contribution of platelets to PAI-1 concentration in plasma of patients with primary and secondary thrombocytosis (1997) (1)
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosis. (1985) (1)
The use of tissue thromboplastins of different origin is a fundamental tool in the initial characterization of FVII defects on "factor VII deficiency (Semin Thromb Hemost 2009;35(4):400-406)". (2010) (1)
Severe prekallikrein ( Fletcher factor ) deficiency due to a compound heterozygosis ( 383 Trp stop codon and Cys 529 Tyr ) Anna (2018) (1)
Behaviour and meat quality of Podolian young bulls (2009) (1)
Oral Contraceptives, Thrombosis and Socio-Ethical Values: An Inevitable Compromise is Needed Based Mainlyon a Careful Evaluation of Potential Users (2005) (1)
Advances in Basic, Laboratory and Clinical Aspects of Thromboembolic Diseases* VENOUS AND ARTERIAL THROMBOPHILIA (1997) (1)
Clotting complications of L-Asparaginase therapy in children with ALL (1986) (1)
Prevalence of Cardiovascular Disorders in African-Americans With Congenital Prekallikrein Deficiency Versus Caucasians-Americans With the Same Defect (2020) (1)
Considerations on a Tentative Classification of FVII Deficiency Suited for Practical Clinical Purposes (2012) (1)
Platelet count and volume in children with renal failure treated with human recombinant erythropoietin. (1991) (1)
Lack of inhibition of ellagic acid induced hypercoagulable state and lack of thrombosis in the dog after PAMBA administration (1977) (1)
Electroimmunoassay of factor IX in patients with liver damage and vitamin K unresponsive coagulation disorder. (1979) (1)
Myelodysplastic syndrome and thrombocytosis: a random association? (1994) (1)
Thrombotic and Haemorrhagic Complications in Patients with Heart Valve Prostheses: A More Complex Matter Than Proper Prothrombin Time Ratios (1993) (1)
The Classification of Congenital Factor X Deficiency and Abnormalities (1990) (1)
Long-term treatment of refractory HIV-related immune thrombocytopenia in a patient with haemophilia A. (1992) (1)
A new family with classical factor X deficiency as demonstrated by electroimmunoassay (1983) (1)
Factor V Antigen Is Decreased in Both Types of Combined Factor V and Factor VIII Congenital Defects (1998) (1)
[BEHAVIOR OF COAGULATION TIME AFTER INTRAPERITONEAL INJECTION OF THROMBIN (EXPERIMENTAL NOTE)]. (1964) (1)
Long-term Safety Outcomes of Prekallikrein Deficiency: A Systematic Literature Review (2018) (1)
Coumarin-induced abnormal factor IX: an immunological study in humans. (1978) (1)
Role of replacement therapy in the evaluation of thrombosis occurring in congenital bleeding conditions (2017) (1)
Lithium carbonate failed to modify the neutropenia associated with large granular lymphocyte proliferation. (1989) (1)
Type I and type II disease in congenital factor XIII deficiency (1986) (1)
Platelet adhesiveness and aggregation in congenital afibrinogenemia. An investigation of three patients with post-transfusion, cross-correction studies between two of them. (1975) (1)
Influence of antiplatelet drugs on beta tg and PF4 levels in patients with transient ischemic attacks. (1985) (1)
Previous thrombosis-free pregnancies are no guarantee that subsequent oral contraception may also remain asymptomatic (2008) (1)
Platelet fibrinogen: subcellular localization by means of immunofluorescent studies in normals and in congenital afibrinogenemia. (1979) (1)
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor. (1992) (1)
Peculiar Congenital Factor VII Defect with the Proposita and Her Mother Showing the Same Compound Heterozygosity for Thr384Met and Arg413Gln (2020) (1)
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders (2018) (1)
Long-term safety outcomes of prekillikrein (Fletcher factor) deficiency: A systematic literature review of case reports. (2019) (1)
Congenital FX Deficiency Rio Tercero: A New Heterozygous Missense Mutation (Cys241Gly) with a Potentiating Effect by a Polymorphism (c. 503-57C>T). (2017) (1)
Deep vein thrombophlebitis of a leg in a young female with heterozygous protein C deficiency taking oral contraceptives. (1990) (1)
In vitro survival studies of a factor VIII concentrate (Kryobulin) (1982) (1)
An immunological investigation of factor VIII associated antigen in combined factor v and factor VIII deficiency (1976) (1)
Factor X antigen--factor X activity discrepancy in coumarin treated patients. No relationship with dilution curve. (1987) (1)
Worldwide Distribution of PK Deficiency: the Defect Seems Mainly Concentrated in West African Countries and the United States (2020) (1)
Heterozygous carrier of G20210A prothrombin mutation used oral contraceptive treatment for 23 years without thrombotic events, and developed cerebral venous thrombosis 1 month after resumption of the medication at the age of 50. (2001) (1)
Homozygous Prekallikrein Deficiency in the USA: Several Patients but Still Few Mutation Studies (2021) (1)
Factor X and pancreatic islet A cell (1982) (1)
Chromogenic substrate (S-2222) factor X assays in the follow-up of coumarin treated patients. No advantage over prothrombin time and/or thrombotest. (1981) (1)
Complications of protein C deficiency in I pregnancy (1996) (0)
Unexpected low prevalence of FVIII gene inversion in severe hemophilia A patients from north-eastern Italy. (1996) (0)
The Poor Reliability of Factor X Chromogenic Assays in Coumarin Treated Patients (1992) (0)
Inhibition by aprotinin. (1993) (0)
: Biphasic sulphinpyrazone-warfarin interaction. (1981) (0)
RANK INJUSTICE IN ITALIAN ACADEMIC MEDICINE (1988) (0)
Taipan viper venom and chromogenic substrate (chromozym Th). Prothrombin assay. No sensitivity to coumarin-induced prothrombin. (1981) (0)
On the Release of von Willebrand Factor from Endothelial Cells after Venous Occlusion (1998) (0)
Erratum to: Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May–Hegglin, Sebastian, Fechtner and Epstein syndromes) (2012) (0)
Blood viscosity and psoriasis. (1982) (0)
Thrombocytosis in Malignancy: A Paraneoplastic Syndrome? (1997) (0)
Contents, Vol. 63, 1980 (1980) (0)
Contents, Vol. 63, 1980 (1980) (0)
Programmed versus non-programmed freezing of umbilical cord blood (2000) (0)
Abstract (2003) (0)
Unusual Association of Hairy Cell Leukemia and Monoclonal Large Granular Lymphocyte Proliferation. (1990) (0)
presence of only the beta-form of protein C in plasma Compound heterozygous protein C deficiency resulting in the (2011) (0)
[Behavior of hematic fibrinogen in leukemias with hyperfibrinolysis]. (1966) (0)
Arg304Gln (FVII Padua) coagulation disorder in a patient with Down Syndrome (trisomy 21): a remarkable observation from Argentina (2020) (0)
The long-term clinical course of acute deep vein thrombosis of the arm: a prospective cohort study (2003) (0)
African and African-American Contribution to the Knowledge of the FVII Padua (Arg304Gln) Defect. (2020) (0)
Contents, Vol. 75, 1986 (1986) (0)
Thrombophilia as a polygenic disease: A study of 24 genetically characterized protein C deficient probands with thrombosis (1999) (0)
Blood Platelet Membranes Symposium (1977) (0)
Reply to: A nucleic acid exchange in Intron F (Intron F-14T>G) in the human plasminogen gene is only a common polymorphism and not a true mutation (2004) (0)
Trypsin clotting time (K-test) in hemophilia A and in hemophilia B1. (1981) (0)
Anti-human FVIII antibodies generated in the mouse by subcutaneous versus intravenous FVIII injection recognise different epitopes in the antigenic moiety (1998) (0)
HIV seroconversion and AIDS related complex (ARC) after the recent use of haemoderivates in a patient with von Willebrand's disease. (1989) (0)
Sensory evaluation of some organoleptic traits of meat from young bulls of 7 genetic types. (1990) (0)
Poster discussionLaser nephelometric evaluation of protein C (1990) (0)
[CORRELATIONS BETWEEN HEMATIC FIBRONOGEN AND SEDIMENTATION VELOCITY IN ACUTE LEUKEMIAS]. (1965) (0)
Contents Vol. 123, 2010 (2010) (0)
10th International Winter Meeting on Coagulation. Basic, Laboratory and Clinical Aspects of Venous and Arterial Thromboembolic Diseases. Bormio, Italy, April 10-16, 2011 (2012) (0)
Hereditary protein S defects: A study of 52 patients and a proposal of a simple classification for practical purposes (1992) (0)
UvA-DARE ( Digital Academic Repository ) D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis : prospective cohort study (1998) (0)
Effect of electrical stimulation and other genetic and environmental factors on colour of lamb meat (2006) (0)
Plasminogen activator inhibitor in plasma and platelets of patients with thrombocythemia (1994) (0)
THE EFFECT OF CHANGES IN THE COAGULATION SYSTEM ON THE PERSISTENCE OF CANCER CELLS IN THE CIRCULATION AND ON THE PRODUCTION OF PULMONARY METASTASES. (1964) (0)
Tissue factor pathway inhibitor activity in factor VII deficiency. (1995) (0)
Use of the Piedmont breed in the production of F1, F2 and backcross young bulls. 1. Rheological characteristics of meat. (1990) (0)
Factor X Friuli (1975) (0)
Tenderness of meat from Podolian young bulls: an objective to be achieved (2005) (0)
The Platelet Specific Proteins During Cardio Pulmonary Bypass (1981) (0)
Which is the outcome of the post-thrombotic syndrome? (1999) (0)
Contribution to the knowledge of the antithyroid activity of some substances with antitubercular activity. Research with radioiodine (1959) (0)
Supplementation of n–3 fatty acids and immune competence of Italian Friesian cows (2004) (0)
Abnormal Platelet Aggregation in Patients with Bartter’s Syndrome (1983) (0)
[Blood, plasma and relative viscosities in psoriasis]. (1982) (0)
The spectrum of factor VII deficiencies and abnormalities. (2004) (0)
Subject Index, Vol. 80, 1988 (1988) (0)
Acquired and Congenital Thrombo-Hemorrhagic Disorders: The Clinical Plot Has Thickened (2018) (0)
Index rerum ad Vol. 51 (1974) (0)
Shelf life and fatty acid profile of meat from Podolian cattle. (2005) (0)
THE PLATELET AGGREGATING PROPERTIES OF TYPE IIB VON WILLEBRAND FACTOR (vWF): THE ROLE OF PLATELET ACTIVATION, FIBRINOGEN AND TWO DISTINCT MEMBRANE RECEPTORS (1987) (0)
disease Reduced von Willebrand factor survival in type Vicenza von Willebrand (2013) (0)
Abstract (2003) (0)
family 20210G/A) affecting the prothrombinase complex in a thrombophilic Combinations of 4 mutations (FV R506Q, FV H1299R, FV Y1702C, PT (2013) (0)
Factor X deficiency due to a compound heterozygosis between a new mutation (Gla72Asp) in exon 2 and an already known one (Gly154Arg) in exon 5: Factor X Mar del Plata 1). (2018) (0)
[Factor XIII deficiency due to lack of both the S and A subunits. (Classification of factor XIII deficiency in 2 groups)]. (1979) (0)
[Migrant thrombophlebitis and blood hypercoagulability caused by probable activation of the Hageman factor-PTA system. (Clinical case)]. (1968) (0)
[The test of the thyroid diseases]. (1961) (0)
Contents Vol. 124, 2010 (2010) (0)
Influence of storage conditions and age at slaughter on lipid oxidation and fatty acid profiles of Gentile di Puglia lambs (2001) (0)
Thromboembolism and Factor VII defect. (1984) (0)
Contents, Vol. 51, 1974 (1974) (0)
Protein C padua 2: A protein C abnormality with a defect in the carboxylated region (1992) (0)
Presence or absence of factor IX in normal platelets. (1994) (0)
Demonstration of a double hereditary pattern for congenital afibrinogenemia (1981) (0)
Index autorum ad Vol. 51 (2004) (0)
An immunological study of prothrombin in liver cirrhosis (1980) (0)
The use of antiproteolytic mixture fails to modify the abnormal von Willebrand factor pattern in myeloproliferative disease. (1988) (0)
[Modern trends in the therapy of congenital and acquired coagulopathies]. (1968) (0)
High platelet count and major neurologic vascular accidents (1992) (0)
Discrepancies between von willebrand factor multimeric composition and other tests in some von willebrand's disease variants (1987) (0)
Peculiar, poorly known, rare congenital bleeding disorders presenting thrombotic events: an understudied chapter of molecular, blood coagulation defects (2020) (0)
State-of-the-Art Review : Prevention of Venous Thromboembolism in Major Orthopedic Surgery (1996) (0)
Prothrombin time using thromboplastins of different origin in hemophilia BM patients (1994) (0)
Heparin Induces Apoptosis in Lymphocytes from B-cell Chronic Lymphocytic Leukemia. (1998) (0)
An acquired prekallikrein deficiency can be diagnosed only after a sure exclusion of a congenital condition. (2020) (0)
Subject Index, Vol. 75, 1986 (1986) (0)
Higher Ratio of Arterial vs Venous Thrombosis in Hemophilia A as Compared with Von Willebrand Disease. (2014) (0)
DIFFERENT PLATELET BINDING SITES ARE PROBABLY INVOLVED IN SPONTANEOUS PLATELET AGGREGATION INDUCED BY IIB VON WILLEBRAND FACTOR IN NORMALS AND IN IIB VON WILLEBRAND'S DISEASE PATIENTS (1989) (0)
Laser nephelometer evaluation of factor IX. (1990) (0)
The slow but progressive disappearance of the patients with the Pro343Ser (FX Friuli) mutation (2020) (0)
The Old and the New in Prekallikrein Deficiency: Historical Context and a Family from Argentina with PK Deficiency due to a New Mutation (Arg541Gln) in Exon 14 Associated with a Common Polymorphysm (Asn124Ser) in Exon 5 (2014) (0)
Peculiar rocket profile in the electroimmunoassay of protein-S-deficient plasma: a clue to diagnosis? (2008) (0)
Fibrinolytic and clinical effects of defibrotide use in le veen shunt (1994) (0)
About the rarity of the mutation Pro343Ser seen in the patients with FX Friuli (2020) (0)
[Coagulation and rheologic parameters in pseudoxanthoma elasticum]. (1982) (0)
are carriers of factor V Leiden: a prospective cohort study Incidence of venous thromboembolism in asymptomatic family members who (2013) (0)
[Importance of nitrogen mustard as a co-adjuvant therapy of an experimental lung tumor]. (1964) (0)
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS The Incidence of Venous Thromboembolism in Asymptomatic Carriers of a Deficiency of Antithrombin, Protein C, or Protein S: A Prospective Cohort Study (2016) (0)
Hancock bioprosthesis and thrombosis. (1981) (0)
Subject Index, Vol. 64, 1980 (1980) (0)
Comparison between Congenital Prekallikrein Deficiency in Humans and Animals (2019) (0)
Acute promyelocytic leukemia with normal blood fibrinogen. A report of two cases. (1967) (0)
Fibrinolytic purpura in a patient with disseminated neuroblastoma. (1966) (0)
Letter: Hemostatic defects in experimental leukemia. (1974) (0)
Contents Vol. 119, 2008 (2008) (0)
Higher prevalence of arterial vs venous disorders in patients with congenital Prekallikrein deficiency (2020) (0)
Bidimensional Immunoelectrophoresis Abnormal Migration of Serum Antithrombin III in Coumarin-Treated Patients (1981) (0)
Isolation and characterization of an antifactor V antibody causing APC resistance from a patient with severe thrombotic manifestations (2002) (0)
Letter: Immunology of factor X. (1974) (0)
Title Page / Table of Contents / Preface (2003) (0)
Evidence for the need of long-term antithrombotic therapy in patients with porcine heterograft heart valve. (1981) (0)
[Behavior of fibrinogenemia in reticulosarcoma and lymphosarcoma]. (1966) (0)
Optimizing the management of thrombosis in the antiphospholipid-antibody syndrome. (1999) (0)
Unsuitability of laser nephelometer in the evaluation of factor VIII antigen. (1989) (0)
Subject Index Vol. 123, 2010 (2010) (0)
STUDIES IN IODINE METABOLISM. II. THREE-POOL SYSTEMS OF IODIDE KINETICS. (1965) (0)
Low Molecular Weight Heparins: Anti-Xa/Aptt And Platelet Aggregation (1981) (0)
Sensory properties and shelf life of Lucanian sausages (2013) (0)
The Significance of Thromboelastography in Comparison with Other Global Clotting Tests (1982) (0)
Antithrombin III levels in cynomolgus monkey recipients of a life-supporting porcine renal xenograft (2003) (0)
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma. (2016) (0)
No Malabsorption of Inorganic Ferrous Iron in Patients with Achylia gastrica (1979) (0)
Captopril-induced changes on active and inactive renin in a patient with factor XII congenital deficiency (1985) (0)
A Comment About the Correct Attribution of the Discovery of FX Friuli Disorder (2012) (0)
Atherosclerosis as a potential risk factor of venous thrombosis (2003) (0)
Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report. (1977) (0)
Book Review / Announcement (1980) (0)
Home Treatment Versus Early Discharge From the Hospital: A Dilemma in the Management of Proximal Vein Thrombosis With Low Molecular Weight Heparins (1997) (0)
Considerations on combined factor VII and factor VIII defect. (1981) (0)
True Congenital Prothrombin Deficiency Due to a <symbol unicode="2018" ascii="`"></symbol>New<symbol unicode="2019" ascii="'"></symbol> Mutation in the Pre-Propeptide (ARG-39 GLN) (2008) (0)
The Last Contribution of Hemophiliacs to Blood Coagulation: Atherosclerosis Is Not Prevented by Hypocoagulability (2013) (0)
FACTOR VIII AND FACTOR XII LEVELS IN BORDERLINE HYPERTENSION (1987) (0)
Antiphospholipid Antibodies Do Not Seem to Be Associated With Deep Vein Thrombosis: A Case Control Study (1997) (0)
Platelet Function in Alcoholics Treated with Disulfiram (1996) (0)
[Levels of proaccelerin (factor V) in leukemias]. (1967) (0)
Intermittent Claudication Revisited: The Value of Medical Therapy (1999) (0)
[Transfusion medicine]. (1997) (0)
Contents, Vol. 64, 1980 (2004) (0)
Bone marrow promyelocytes and blood fibrinogen in acute myelogenous leukemia. (1966) (0)
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities (1999) (0)
Haemorheological parameters in alopecia areata. (1985) (0)
[Relation between hematic fibrinogen and sedimentation rate of erythrocytes in Hodgkin's disease, reticulosarcoma and lymphosarcoma]. (1965) (0)
Chronic B-cell lymphoproliferative disease: relationship between immunophenotype and clinical stage. (1990) (0)
The Release of Tissue Factor Pathway Inhibitor and Platelet Factor 4 After Heparin Injection in Patients with Thrombocytosis. (1997) (0)
The significance of essential thrombocythemia in advanced age (1998) (0)
The discovery of factor X (2004) (0)
Points: Biphasic sulphinpyrazone-warfarin interaction (1981) (0)
Heterozygous Deletion of the 3' Portion of Factor X Gene in a Family with Factor X Deficiency. (1989) (0)
Transient blocking coagulation inhibitor in a 18-month-old boy. (1982) (0)
Book Review – Buchbesprechung – Livre nouveau / Varia (1976) (0)
Contact phase of blood coagulation and thrombosis and hypertension: The conundrum has to be clarified (2019) (0)
Contents, Vol. 81, 1989 (1989) (0)
Application of bio-based polymers for fresh meat packaging (2008) (0)
[Attempted prevention of thromboembolic disease in cardiac surgery with calcium heparinate. Our experience]. (1977) (0)
Rheological and clotting changes in chronic cor pulmonale. (1981) (0)
Proven or Highly Probable Factor VII Arg304Gln (FVII Padua) Homozygous Defect: A Mutation that Occurred in Different Areas of the World Which Were Related or Unrelated With Known Forced or Spontaneous Migratory Patterns (2019) (0)
Platelet Aggregation and Thrombophoresis in Thrombocythemia (1980) (0)
Discrepancies between chromogenic methods in the evaluation of protein C abnormalities (1992) (0)
Idiopathic myelofibrosis serum induces increased DNA synthesis in BALB/c 3T3 cells. (1990) (0)
PF 4 assay by an ELISA method: a good correlation with the usual RIA method. (1987) (0)
Thrombotic and hemorrhagic accidents in a large cohort of patients with thrombocytosis (1991) (0)
Suprarenal gland hemorrhage: A bleeding manifestation that may be caused by thrombosis of efferent veins (2018) (0)
New data on FII, FV, FIX and thrombomodulin defects: blood keeps clotting in normal and in peculiar ways (2018) (0)
A NEW PLATELET DISFUNCTION CHARACTERIZED BY SPONTANEOUS PLATELET AGGREGATION AND ENHANCED von WILLEBRAND FACT0R-PLATELET INTERACTION (1987) (0)
Disappearance of FVIII inhibitors in a severe hemophilia A neonate after steroid treatment correlated with a cytokine shift toward a T-helper 2 pattern. (2000) (0)
[Action of purified ellagic acid on coagulation time, compared with crude ellagic acid]. (1966) (0)
Apparent “inhibition” as tested by means of the dilution curve system in patients with clotting defect due to liver damage (1977) (0)
Triggering factors for thrombotic manifestations in congenital defects of clotting inhibitors (1992) (0)
Subject Index, Vol. 63, 1980 (1980) (0)
[Correlation between uremia and fibrinolysis in leukemia]. (1967) (0)
Activated partial thromboplastin time as determined by a chromogenic substrate (Parthochrom): Comparison with a conventional clotting method (1991) (0)
Subject Index, Vol. 63, 1980 (1980) (0)
ON THE DISCREPANT POST‐DDAVP INCREASE OF FVIII:C AND VON WILLEBRAND FACTOR IN SOME PATIENTS WITH SEVERE VON WILLEBRAND'S DISEASE (1995) (0)
Correction to: New clotting disorders that cast new light on blood coagulation and may play a role in clinical practice (2018) (0)
Comments on the significance of differences between thrombotest and normotest in the study of coumarin plasma. (1989) (0)
[INFLUENCE OF STRESS ON FIBRINOGEN AND HEMATIC FIBRINOLYSIS (EXPERIMENTAL NOTE)]. (1965) (0)
9th International Winter Meeting on Coaugulation (2009) (0)
A first generalization of Dintenfass' equation. (1979) (0)
Subject Index, Vol. 81, 1989 (1989) (0)
Proaccelerin Levels in Leukemias. (1967) (0)
[Euglobulinic fibrinolysis and hematic fibrinogen in simple obesity]. (1972) (0)
Short communication Sustainability and welfare of Podolian cattle (2005) (0)
Detection of the carrier state in congenital “true” prothrombin deficiency (1988) (0)
Behaviour of antithrombin III abnormalities in the crossed immunoelectrophoresis system. (1985) (0)
[Left side mass (pseudosplenomegaly) caused by a large retroperitoneal ganglioneuroma]. (1988) (0)
Fatty acid composition and cholesterol content of beef from Podolian and Limousine x Podolian cattle. (2002) (0)
[Pathology of the oral cavity in patients with congenital coagulopathies and HIV infections]. (1989) (0)
A family with factor-XI deficiency due to a compound heterozygosis between Gln 47 Pro (new mutation) in exon 3 and Leu 619 Pro in exon 15 (2014) (0)
[Contribution to the knowledge of the hemorrhagic syndrome induced by thrombin. Behavior of factors II, V and VII]. (1965) (0)
Regional fibrinolytic study in coronary artery disease. (1982) (0)
Different fatherhood as a possible explanation for difficult pedigrees in coagulation defects: only ‘mater semper certa est’ (2005) (0)
[Influence of thrombin on fibrinogen and on fibrinolysis and blood proteolysis]. (1965) (0)
Subject Index Vol. 124, 2010 (2010) (0)
"Anti-platelet antibodies" in HIV infected haemophiliacs. (1990) (0)
[STUDY OF HEMATIC FIBRINOGEN IN ACUTE AND CHRONIC LEUKEMIAS]. (1965) (0)
In vitro stability studies of a Factor IX concentrate (Bebulin). (1983) (0)
Contents Vol. 32, 2002 (2002) (0)
An acquired prekallikrein deficiency can be diagnosed only after a sure exclusion of a congenital condition. (2020) (0)
Further Data about the Clotting Insignificance of Coumarin-lnduced Prefactors (1981) (0)
A Rare Cause of Isolated Prothrombin Time Prolongation: Congenital Factor X Deficiency. (2021) (0)
Subject Index Vol. 119, 2008 (2008) (0)
Contents, Vol. 80, 1988 (1988) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Antonio Girolami?

Antonio Girolami is affiliated with the following schools:

Antonio Girolami's Academic­Influence.com Rankings

Antonio Girolami's Degrees

Similar Degrees You Can Earn

Why Is Antonio Girolami Influential?

Antonio Girolami's Published Works

Published Works

What Schools Are Affiliated With Antonio Girolami?

Antonio Girolami's AcademicInfluence.com Rankings